Pan-cancer analysis suggests that LY6H is a potential biomarker of diagnosis, immunoinfiltration, and prognosis.

Autor: Haifei Qin^1,2, Honglong Lu^1,2, Chongjiu Qin^1,2, Xinlei Huang^1,2, Kai Peng^1,2, Yuhua Li^1,2, Chenlu Lan^1,2, Aoyang Bi^1,2, Zaida Huang^1,2, Yongguang Wei^1,2, Xiwen Liao^1,2, Tao Peng^1,2 pengtaogmu@163.com, Guangzhi Zhu^1,2 zhuguangzhi0792@hotmail.com

Publikováno v: Journal of Cancer. 2024, Vol. 15 Issue 17, p5515-5539. 25p.

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)

Autor: Argani P, Iacobuzio-Donahue C, Ryu B, Christophe Rosty, Goggins M, Re, Wilentz, Sr, Murugesan, Sd, Leach, Jaffee E, Cj, Yeo, Jl, Cameron, Se, Kern, Rh, Hruban

Publikováno v: Europe PubMed Central

Effective new markers of pancreatic carcinoma are urgently needed. In a previous analysis of gene expression in pancreatic adenocarcinoma using serial analysis of gene expression (SAGE), we found that the tag for the mesothelin mRNA transcript was pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::671935d644b050650e33dcd6beb071e5
http://europepmc.org/abstract/med/11751476

Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients

Autor: Rh, Hruban, Pd, Sturm, Rj, Slebos, Re, Wilentz, Ar, Musler, Cj, Yeo, Ta, Sohn, Marie-Louise van Velthuysen, Gj, Offerhaus

Publikováno v: Europe PubMed Central

It can be difficult to distinguish benign bile duct proliferations (BDPs) from well-differentiated metastatic peripancreatic adenocarcinomas on histological grounds alone. Most peripancreatic carcinomas harbor activating point mutations in codon 12 o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2aa08ea8b63c622639b7a79bd9d0792a
http://europepmc.org/abstract/med/9327727

CAR T cells in solid tumors: challenges and opportunities.

Autor: Marofi, Faroogh¹ (AUTHOR), Motavalli, Roza^2,3 (AUTHOR) Rozamotavalli@gmail.com, Safonov, Vladimir A.⁴ (AUTHOR), Thangavelu, Lakshmi⁵ (AUTHOR), Yumashev, Alexei Valerievich⁶ (AUTHOR), Alexander, Markov⁷ (AUTHOR), Shomali, Navid⁸ (AUTHOR), Chartrand, Max Stanley⁹ (AUTHOR), Pathak, Yashwant¹⁰ (AUTHOR), Jarahian, Mostafa¹¹ (AUTHOR), Izadi, Sepideh⁸ (AUTHOR), Hassanzadeh, Ali⁸ (AUTHOR), Shirafkan, Naghmeh⁸ (AUTHOR), Tahmasebi, Safa⁸ (AUTHOR), Khiavi, Farhad Motavalli¹² (AUTHOR) farhad.motavalli@gmail.com

Publikováno v: Stem Cell Research & Therapy. 1/25/2021, Vol. 12 Issue 1, p1-16. 16p.

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.

Autor: Heinrich, Marie-Christine¹ ma.heinrich@uke.de, Göbel, Cosima¹ c.goebel@uke.de, Kluth, Martina¹ m.kluth@uke.de, Bernreuther, Christian² c.bernreuther@uke.de, Sauer, Charlotte¹ charlottesauer4@gmail.com, Schroeder, Cornelia³ cor.schroeder@uke.de, Möller-Koop, Christina¹ c.koop@uke.de, Hube-Magg, Claudia¹ c.hube@uke.de, Lebok, Patrick¹ p.lebok@uke.de, Burandt, Eike¹ e.burandt@uke.de, Sauter, Guido¹ g.sauter@uke.de, Simon, Ronald¹ r.simon@uke.de, Huland, Hartwig⁴ hhuland@uke.de, Graefen, Markus⁴ graefen@uke.de, Heinzer, Hans⁴ heinzer@uke.de, Schlomm, Thorsten^4,5 tschlomm@uke.de, Heumann, Asmus³ aheumann@uke.de

Publikováno v: BMC Cancer. 5/31/2018, Vol. 18 Issue 1, p1-9. 9p. 1 Color Photograph, 3 Charts, 4 Graphs.